DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Taro Pharmaceutical Indus Q3 EPS $1.76 Beats $1.54 Estimate, Sales $147.683M Miss $172.01M Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.54 by 14.29 percent. This is a 28.47 percent increase over earnings of $1.37 per share

Benzinga · 02/03/2020 22:24

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.54 by 14.29 percent. This is a 28.47 percent increase over earnings of $1.37 per share from the same period last year. The company reported quarterly sales of $147.683 million which missed the analyst consensus estimate of $172.01 million by 14.14 percent. This is a 16.27 percent decrease over sales of $176.381 million the same period last year.